TALEN

TALEN1-scube1

ID

ZDB-TALEN-221108-1

Name

TALEN1-scube1

Previous Names

None

Target

scube1 (1)

Target Sequence 1

5' - CCTGGGACGTCTGTTT - 3'

Target Sequence 2

5' - GACATCTAAAGTATTT - 3'

Disclaimer

Although ZFIN verifies reagent sequence data, we recommend that you conduct independent sequence analysis before ordering any reagent.

Note

This TALEN has the SNP rs501321867.

Genome Resources

None

Target Location

Constructs

No data available

Genomic Features

Genomic Feature	Affected Genomic Regions
as401	scube1
as402	scube1

Expression

Gene expression in Wild Types + TALEN1-scube1

No data available

Phenotype

Phenotype resulting from TALEN1-scube1

No data available

Phenotype of all Fish created by or utilizing TALEN1-scube1

Phenotype	Fish	Conditions	Figures
whole organism scube3 expression increased amount, abnormal	scube1^as401/as401 (AB)	standard conditions	Fig. S2 from Tsao et al., 2021
whole organism scube2 expression increased amount, abnormal	scube1^as401/as401 (AB)	standard conditions	Fig. S2 from Tsao et al., 2021
intersegmental vein endothelial tip cell decreased speed, abnormal	scube1^as401/as401; ci5Tg; y7Tg (AB)	standard conditions	Fig. 4 from Tsao et al., 2021
somite U-shaped, exacerbated	scube1^as401/as401; scube2^as403/as403 (AB)	standard conditions	Fig. S3 from Tsao et al., 2021
post-vent region curvature, exacerbated	scube1^as401/as401; scube2^as403/as403 (AB)	standard conditions	Fig. S3 from Tsao et al., 2021
dorsal aorta decreased width, abnormal	scube1^as401/as401; scube2^as403/as403; ci5Tg; y7Tg (AB)	standard conditions	Fig. 3 from Tsao et al., 2021
subintestinal vein decreased length, exacerbated	scube1^as401/as401; scube2^as403/as403; ci5Tg; y7Tg (AB)	standard conditions	Fig. 6 from Tsao et al., 2021
intersegmental vein filopodium decreased amount, abnormal	scube1^as401/as401; scube2^as403/as403; ci5Tg; y7Tg (AB)	standard conditions	Fig. 4 from Tsao et al., 2021
intersegmental vein endothelial cell decreased amount, exacerbated	scube1^as401/as401; scube2^as403/as403; ci5Tg; y7Tg (AB)	standard conditions	Fig. 3 from Tsao et al., 2021
intersegmental vein endothelial tip cell decreased speed, exacerbated	scube1^as401/as401; scube2^as403/as403; ci5Tg; y7Tg (AB)	standard conditions	Fig. 4 from Tsao et al., 2021
posterior cardinal vein decreased width, abnormal	scube1^as401/as401; scube2^as403/as403; ci5Tg; y7Tg (AB)	standard conditions	Fig. 3 from Tsao et al., 2021
intersegmental vein blood circulation process efficacy, exacerbated	scube1^as401/as401; scube2^as403/as403; sd2Tg; y1Tg (AB)	standard conditions	Fig. 2 from Tsao et al., 2021
intersegmental vein length, exacerbated	scube1^as401/as401; scube2^as403/as403; sd2Tg; y1Tg (AB)	standard conditions	Fig. 2 from Tsao et al., 2021
intersegmental vein width, exacerbated	scube1^as401/as401; scube2^as403/as403; sd2Tg; y1Tg (AB)	standard conditions	Fig. 2 from Tsao et al., 2021
dorsal longitudinal anastomotic vessel width, exacerbated	scube1^as401/as401; scube2^as403/as403; sd2Tg; y1Tg (AB)	standard conditions	Fig. 2 from Tsao et al., 2021
dorsal longitudinal anastomotic vessel morphology, abnormal	scube1^as401/as401; scube2^as403/as403; sd2Tg; y1Tg (AB)	standard conditions	Fig. 2 from Tsao et al., 2021
dorsal longitudinal anastomotic vessel decreased size, abnormal	scube1^as401/as401; scube2^as403/as403; sd2Tg; y1Tg (AB)	standard conditions	Fig. 2 from Tsao et al., 2021

Citations